Clinical Trial Update: Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells [Phase 1]

View source ↗

Summary

The update describes a Phase 1 trial evaluating viral-specific T cell therapy for cytomegalovirus infections, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Viremia

Drugs mentioned

• Viral-specific T cell therapy

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: CMV Infection, Cytomegalovirus Infections | Phase 1 | Status: TERMINATED